HIV: The benefits of prophylaxis of tuberculosis are confirmed

(ANRS) Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.